From laboratory to clinic: rationale for biologic therapy.
Mehlis
Stephanie
S
Department of Dermatology, Northwestern University Medical School, 675 N. St. Clair Street, Chicago, IL 60611, USA.
Gordon
Kenneth B
KB
D001691:Biological Therapy / Q000379:methods*; D002908:Chronic Disease; D003131:Combined Modality Therapy; D016503:Drug Delivery Systems; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007167:Immunotherapy / Q000379:methods; D008297:Male; D011379:Prognosis; D011565:Psoriasis / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy*; D018570:Risk Assessment; D012720:Severity of Illness Index; D013601:T-Lymphocytes / Q000187:drug effects*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents